Long COVID patients show immunological improvement two years after infection

  • 📰 medical_xpress
  • ⏱ Reading Time:
  • 46 sec. here
  • 7 min. at publisher
  • 📊 Quality Score:
  • News: 39%
  • Publisher: 51%

Medicine Research News News

Medicine Research,Health Research News,Health Research

Biomarkers for long COVID that were present in patients at eight months have largely resolved by 24 months among a cohort of people who contracted COVID-19 during Australia's first wave.

Long COVID patients show immunological improvement two years after infection retrieved 18 April 2024 from https://medicalxpress.com/news/2024-04-covid-patients-immunological-years-infection.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Aug 16, 2023New study uncovers why boys born to mothers with HIV are at greater risk of health problems and death in infancyUse this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page.

Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.

Medicine Research Health Research News Health Research Health Science Medicine Science

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 101. in UK

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

COVID-19 antibody discovery could explain long COVIDUVA Health researchers have discovered a potential explanation for some of the most perplexing mysteries of COVID-19 and long COVID. The surprising findings could lead to new treatments for the difficult acute effects of COVID-19, long COVID, and possibly other viruses.
Source: medical_xpress - 🏆 101. / 51 Read more »

Biomarkers of the middle-aged brain could predict cognitive health in old age, say researchersThe middle-aged brain could provide a window into future cognitive health, researchers write in a review publishing March 19 in the journal Trends in Neurosciences. The team reviewed evidence from human and animal studies suggesting that middle age—commonly considered as the period between 40 and 60 or 65 years of age—marks a shift in brain aging.
Source: medical_xpress - 🏆 101. / 51 Read more »

Sex-specific blood biomarkers linked to memory changes in middle-aged adults: The Framingham heart studyDementia refers to a set of symptoms marked by a decline in cognitive abilities, including memory, language, reasoning and everyday tasks. It can result from various causes, such as Alzheimer's disease, vascular problems, traumatic brain injuries and other health issues.
Source: medical_xpress - 🏆 101. / 51 Read more »

Researchers discover skin biomarkers in infants that predict early development of food allergiesFood allergies occur often in childhood and can be severe or even fatal. Researchers at National Jewish Health are working to develop a program to prevent food allergies and have now identified early predictors of the condition.
Source: medical_xpress - 🏆 101. / 51 Read more »

Soluble Immune Checkpoint Factors in Blood as Potential Biomarkers for ICI Cancer ImmunotherapyResearchers have identified soluble immune checkpoint factors in the blood that can be used as potential biomarkers to assess the efficacy of cancer immunotherapy with immune checkpoint inhibitors (ICIs). This finding could have significant implications for personalized cancer treatment.
Source: medical_xpress - 🏆 101. / 51 Read more »

Artificial intelligence analysis of DNA fragmentomes and protein biomarkers noninvasively detects ovarian cancerA blood-based machine learning assay that combines cell-free DNA (cfDNA) fragment patterns and levels of the proteins CA125 and HE4 could differentiate patients with ovarian cancer from healthy controls or patients with benign ovarian masses, according to a retrospective study presented at the American Association for Cancer Research (AACR) Annual...
Source: medical_xpress - 🏆 101. / 51 Read more »